Lexeo Therapeutics’ $95 Million Private Placement

Paul Hastings LLP advised J.P. Morgan and Leerink Partners as co-lead placement agents, and Stifel co-placement agent, in the transaction.Lexeo Therapeutics, Inc. (Nasdaq: LXEO) has entered into…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now